BIFIDO Co., Ltd. (KOSDAQ:238200)
3,565.00
-15.00 (-0.42%)
Last updated: Aug 12, 2025
BIFIDO Company Description
BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally.
It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems.
The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea.
BIFIDO Co., Ltd.
Country | South Korea |
Founded | 1999 |
Industry | Pharmaceutical Preparations |
Employees | 83 |
Contact Details
Address: 23-16 Nonggongdanji-gil Hongcheon South Korea | |
Phone | 82 3 3435 4962 |
Website | bifido.com |
Stock Details
Ticker Symbol | 238200 |
Exchange | KOSDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | KRW |
SIC Code | 2834 |